NY Files Charges Against J&J Over Opioids -- Update
September 17 2020 - 12:40PM
Dow Jones News
By Stephen Nakrosis
New York State Gov. Andrew Cuomo Thursday said the state has
filed charges against Johnson & Johnson and several of its
subsidiaries, alleging the company fraudulently mischaracterized
the safety and effectiveness of opioid drugs in an effort to expand
the market.
The actions are a part of an effort to recover $2 billion in
insurance premium overcharges for New York residents, the state's
Department of Financial Services said in a release.
The department said it has initiated administrative proceedings
against J&J and its subsidiaries Janssen Pharmaceutica, Janssen
Pharmaceuticals, and Ortho-McNeil-Janssen Pharmaceuticals.
The claim alleges that J&J has "had a long-standing and
multi-faceted leading role in originating, supplying, facilitating,
and actively creating a dangerous market for opioids for chronic
pain treatment."
The department alleges J&J violated parts of the state's
insurance law, and that each fraudulent prescription constitutes a
separate violation.
J&J said in a statement that its marketing and promotion of
prescription opioid pain medications was "appropriate and
responsible."
"Janssen provided these medicines for doctors treating patients
suffering from pain and worked with regulators to provide
appropriate information about their risks and benefits--everything
you'd expect a responsible company to do," the company said.
A hearing is scheduled for Jan. 25.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 17, 2020 12:25 ET (16:25 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024